Healthcare Services

Gene Editing Market Forecast Through 2030 Featuring Industry Drivers And Opportunities

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Gene Editing Market In 2026 And How Much Will It Reach By 2030?

The gene editing market has experienced substantial growth in recent years. Its value is projected to increase from $10.31 billion in 2025 to $12.28 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.0%. The historical growth can be attributed to the discovery of CRISPR-Cas systems, significant academic gene editing research, the development of ZFN and TALEN technologies, the availability of research funding, and the ongoing expansion of molecular biology tools.

The gene editing market is projected to experience substantial expansion over the coming years, reaching a valuation of $24.45 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.8%. This anticipated growth is linked to factors such as the clinical application of gene editing therapies, the approval of new regulations, advancements in next-generation editing instruments, a rise in industry investments, and the broader development of precision medicine. Key developments expected during this period include the swift embrace of CRISPR-based technologies, the extended application of gene editing in cell line engineering, increased utilization within agricultural and animal genetics, an uptick in therapeutic gene editing research, and a growing need for precise genome modifications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What Are The Main Drivers Accelerating The Growth Of The Gene Editing Market?

The increasing occurrence of genetic disorders is anticipated to drive the expansion of the gene editing global market in the future. Genetic disorders are defined as a group of health conditions resulting from irregularities or changes in a person’s DNA. Such disorders can be passed down from parents or emerge from unforeseen genetic mutations. They lead to diverse health problems or medical states, which may manifest at birth or later in an individual’s life. Gene editing offers significant promise for addressing severe genetic illnesses like sickle cell disease, Huntington’s disease, β-thalassemia, cystic fibrosis, Alzheimer’s, and Parkinson’s. As an example, in April 2023, the National Library of Medicine (NLM), a US-based medical library, reported that approximately 6.7 million Americans age 65 and older are projected to be living with Alzheimer’s dementia (AD) in 2023. This figure could escalate to 13.8 million by 2060, unless medical advancements emerge to prevent, slow, or cure AD. Consequently, as genetic disorders become more prevalent, they are projected to stimulate the gene editing market.

What Segment Types Are Included In The Gene Editing Market Analysis?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Which Trends Are Expected To Shape The Gene Editing Market?

Leading firms in the gene editing markets are introducing cutting-edge technologies, such as methods employing specialized cell-penetrating peptides, which offer benefits over current practices, to secure a competitive edge. This strategy also has the potential to accelerate the development of advanced cell-based treatments for conditions like cancer. For example, in April 2023, Penn Medicine, a prominent multi-hospital health system in the US, identified that protein fragments, typically used by some viruses to enter cells, could similarly facilitate the entry of CRISPR-Cas gene editing molecules into cells and their DNA-containing nuclei with remarkable effectiveness and low toxicity to cells. Researchers believe this new approach will be particularly useful for modifying T cells and other patient-derived cells for the creation of cell therapies. A specific application could be CAR T (chimeric antigen receptor T cell) therapy, which involves using a patient’s specially altered immune cells to combat cancer. This novel method for genetic engineering cells promises considerable enhancements in speed, efficacy, and a decrease in cellular toxicity when compared to existing methods.

Which Industry Players Are Present In The Gene Editing Market?

Major companies operating in the gene editing market are AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., ToolGen Inc., Mirus Bio LLC

Access The Complete Gene Editing Market Report:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Which Region Has The Strongest Presence In The Gene Editing Market?

North America was the largest region in the gene editing market in 2025. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gene Editing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Browse Through More Reports Similar to the Global Gene Editing Market 2026, By The Business Research Company

Recombinant Dna Technology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Genes Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Advanced Drug Delivery Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795